Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Operationalising the capability approach as an outcome measure in public health: The development of the OCAP-18.

Lorgelly PK, Lorimer K, Fenwick EA, Briggs AH, Anand P.

Soc Sci Med. 2015 Oct;142:68-81. doi: 10.1016/j.socscimed.2015.08.002. Epub 2015 Aug 6.

PMID:
26291444
2.

Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6.

Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD; ISPOR-SMDM Modeling Good Research Practices Task Force.

Value Health. 2012 Sep-Oct;15(6):835-42. doi: 10.1016/j.jval.2012.04.014.

3.

Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.

Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD; ISPOR-SMDM Modeling Good Research Practices Task Force.

Med Decis Making. 2012 Sep-Oct;32(5):722-32.

PMID:
22990087
4.

Outcome measurement in economic evaluations of public health interventions: a role for the capability approach?

Lorgelly PK, Lawson KD, Fenwick EA, Briggs AH.

Int J Environ Res Public Health. 2010 May;7(5):2274-89. doi: 10.3390/ijerph7052274. Epub 2010 May 6. Review.

5.

Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.

Hoomans T, Fenwick EA, Palmer S, Claxton K.

Value Health. 2009 Mar-Apr;12(2):315-24. doi: 10.1111/j.1524-4733.2008.00431.x. Epub 2008 Jul 24.

6.
7.

Cost-effectiveness acceptability curves and a reluctance to lose.

Severens JL, Brunenberg DE, Fenwick EA, O'Brien B, Joore MA.

Pharmacoeconomics. 2005;23(12):1207-14. Review.

PMID:
16336015

Supplemental Content

Loading ...
Support Center